Valuation : Dr. Reddy's Laboratories Limited

Market Cap 954B 10.08B 8.67B 8.16B 7.45B 13.93B 13.97B 96.72B 37.39B 488B 37.87B 37.04B 1,556B P/E 2027 *
25.4x
P/E 2028 * 19.7x
Enterprise Value 922B 9.75B 8.39B 7.89B 7.2B 13.47B 13.51B 93.52B 36.15B 472B 36.62B 35.82B 1,504B EV / Sales 2027 *
2.62x
EV / Sales 2028 * 2.3x
Free-Float
69.71%
Yield 2027 *
0.66%
Yield 2028 * 0.73%
1 day-0.78%
1 week-2.78%
Current month-1.72%
1 month-2.55%
3 months-10.39%
6 months-12.19%
Current year-9.92%
1 week 1,142.55
Extreme 1142.55
1,179.9
1 month 1,142.55
Extreme 1142.55
1,207.9
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2019
Director of Finance/CFO - 31/07/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 12/05/2014
Chairman 65 01/04/2013
Director/Board Member 65 24/10/2018
Date Insider Type Main position Quantity % Market Cap. Importance
01/04/26 Other

Global Head of Quality and PV

35,600 0.0043% -
18/12/25 Other

Chairman

85,738,125 10.2732%
18/12/25 Other

Director

12,717,090 1.5238%
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%-2.78%-9.74%+2.58% 10.18B
-0.88%-2.15%+58.05%+105.26% 1,024B
-1.15%+2.68%+54.25%+74.19% 663B
-1.44%+0.38%+20.65%+76.13% 453B
-0.95%+0.23%+30.91%+37.78% 352B
-3.18%+1.78%+22.62%+41.55% 304B
+0.30%+0.67%+0.60%+11.25% 252B
-1.55%+1.11%+54.15%+75.59% 236B
+0.02%+2.24%-13.83%-55.80% 206B
-0.15%+3.65%+31.24%+103.39% 187B
Average -0.96%+0.93%+24.89%+47.19% 368.86B
Weighted average by Cap. -1.04%+0.61%+37.53%+66.72%

Financials

2027 *2028 *
Net sales 352B 3.72B 3.2B 3.01B 2.75B 5.14B 5.15B 35.68B 13.79B 180B 13.97B 13.67B 574B 393B 4.15B 3.57B 3.36B 3.07B 5.73B 5.75B 39.82B 15.39B 201B 15.59B 15.25B 641B
Net income 37.21B 393M 338M 318M 291M 543M 545M 3.77B 1.46B 19.06B 1.48B 1.45B 60.7B 48.98B 518M 445M 419M 382M 715M 717M 4.97B 1.92B 25.08B 1.94B 1.9B 79.89B
Net Debt -31.58B -334M -287M -270M -247M -461M -463M -3.2B -1.24B -16.17B -1.25B -1.23B -51.52B -51.62B -546M -469M -441M -403M -754M -756M -5.23B -2.02B -26.43B -2.05B -2B -84.2B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
07/09/26 1,145.00 -0.78% 29,778
04/09/26 ₹1,154.00 -0.09% 20,596
03/09/26 ₹1,155.00 -0.52% 27,997
02/09/26 ₹1,161.00 -0.85% 18,399
01/09/26 ₹1,171.00 +0.52% 32,241
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,145.00INR
Average target price
1,265.77INR
Spread / Average Target
+10.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!